213
Lisoló ya nsango oyo ekoki kosalema:
NEWCGX e révolutionner diagnostic médical na technologie ya imagerie basée na AI .
NewCGX, a California-based company specializing in medical imaging and analysis, has launched a new platform that promises to improve the accuracy and efficiency of clinical diagnosis using artificial intelligence (AI) and deep learning algorithms. The platform, called NewCGX Vision, integrates various modalities of imaging data, such as X-ray, MRI, CT, and ultrasound, and applies machine learning models to generate detailed and personalized reports for doctors and patients.
Engebene na mobandisi mpe mokambi ya NewCGX, DR. Peter Wang, Vision ezali komonisa bopumbwi monene na tekiniki ya bilili ya monganga, lokola ekoki koyeba bozangi ya mayele mpe lolenge oyo miso ya moto ekoki kozanga to kozanga kotala. "tondimi ete avenir ya nkisi ezali na ba données-driven decision-making and precision médicament," elobi dr dr’orith} "uver4}} uver5}" Tozali na makoki ya kososola motango monene ya ba données ya imagerie na tango ya solo mpe kopesa mayele ya kosala oyo ekoki kotombola diagnostic, planification ya traitement mpe bolandi.".
One of the key features of Vision is its ability to process multiple imaging modalities simultaneously and integrate them into a cohesive 3D model. This means that doctors can compare and correlate different views of a patient's anatomy and physiology, and detect anomalies or changes over time that may indicate disease progression or response to therapy. Moreover, Vision can generate quantitative measurements of tissue characteristics, such as density, perfusion, and elasticity, which can Salisa kokesenisa ba lésions bénines mpe malignantes, ko estimation ya pronostic, mpe ko guider ba traitements ya précision.
Another advantage of Vision is its intuitive and interactive interface, which allows doctors and patients to navigate and explore the imaging data in a user-friendly way. For instance, doctors can zoom in and out, rotate or slice the 3D model, and annotate or highlight specific regions of interest, while patients can view their own data and learn more about their condition and treatment options. Vision also supports secure and seamless data sharing and collaboration among healthcare providers, which can improve communication and coordination Na makambo ya mindondo. .
NEWCGX esi emekaka mpe e validaki vision na ba environnements cliniques ebele, na kati na yango oncologie, cardiologie, neurologie, mpe orthopédique, mpe ezui ba retours positifs epai ya basaleli. na ndakisa, dr{1}} Amanda Chang, radiologiste na lopitalo ya Stanford, akumisaka vision mpo na makoki na yango ya kobimisa ba caractéristiques ya kobombama ya ba tumeurs mpe ya assist na ba décisions ya ba tumeurs . Biopsie, lipaso, to radiothérapie," elobi dr. Chang. "Ebombaka ntango mpe ekitisaka mabunga, mpe na nsuka ebongisaka mbano ya mobeli.".
NewCGX plans to expand the application of Vision to other areas of medicine, such as pediatrics, geriatrics, and preventive health, and to integrate more advanced AI algorithms, such as natural language processing and predictive analytics, into the platform. The company also aims to collaborate with academic and industry partners to further validate and refine the technology, and to obtain regulatory approval from the FDA and other agencies. With its vision for a Système ya soins de santé oyo ekambami na ba données mpe oyo esalemi